Analystreport

Selecta Biosciences, Inc. (NASDAQ: SELB) had its price target lowered by analysts at HC Wainwright from $6.00 to $4.00.

Selecta Biosciences, Inc.  (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report